Dermatology - AXIS Clinicals

Dermatology Studies

Partner with our experienced Transdermal/ Topical team

We are able to rapidly recruit 300 volunteers as required by FDA guidance.

Research your transdermal drug-delivery systems (TDDS) and topical products at AXIS

Vasoconstrictor studies

AXIS has successfully conducted more than 50 dermatology studies for topical corticosteroid drug products.

Adhesion studies

Our experienced and trained staff for adhesion scoring makes us uniquely qualified to perform adhesion studies for TDDS

Dermal Open Flow Microperfusion

Unlike traditional methods, dOFM provides time-resolved PK/PD data, offering a deeper understanding of drug behavior in a clinical setting.

Irritation/Sensitization:

Our outpatient study unit is designed to seamlessly conduct large-scale dermatology clinical studies, enrolling up to 300 volunteers while ensuring subject safety, compliance, and efficient study execution.

Studies

Our dedicated 6,000 sq ft dermatology facility is designed to ensure seamless workflow for large outpatient irritation and sensitization studies requiring as many as 300 volunteers, supporting high-quality dermatology clinical trials. We also have three additional flexible study units, with a total capacity of 234 beds for inpatient studies.

The AXIS team has highly trained and experienced staff for dermatology scoring and assessments.

What the industry is saying about AXIS

"
Working with AXIS has been a game-changer for us. Their teams truly understand the unique challenges of conducting complex pharmacology cardiac safety TQT projects and have been incredibly responsive and proactive throughout the process. They’ve made what could have been a stressful journey much smoother, keeping timelines on track (exceeding expectations with seamless clinical and bioanalysis within same building and delivering high-quality data results. I highly recommend them as a partner.

"
AXIS has been our long-time reliable partner for clinical research. Their team understands the challenges of developing 505(b)(2) products and has provided solid support throughout our clinical development program of studies. They’ve helped us stay on track and navigate a complex process with professionalism and quality data. I would recommend them to all of my industry contacts looking for a dependable CRO partner.

"
AXIS has consistently delivered outstanding support as a Phase 1 site partner. Their ability to recruit and enroll subjects quickly and efficiently has been a key factor in keeping our timelines on track. The team is professional, responsive, and well-organized, ensuring the smooth execution of even the most complex pharmacology studies. We value their expertise and look forward to continued collaboration.

"
We've worked with AXIS Clinicals USA on several Phase 1 studies, and their ability to quickly enroll subjects has been a huge advantage for us. They’re efficient, easy to work with, and always meet our timelines. Their team handles everything smoothly, which makes our job easier. We’re grateful for their support and look forward to working with them again.

Scroll to see more